Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase IV Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

NCT00163618 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00163618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00163618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase IV Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
June 30, 2005
Completion date
July 31, 2006
Enrollment
Not reported
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

encephalitis, tick-borne